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Abstract
Purpose Although the importance of rational prescribing is
generally accepted, the teaching of pharmacotherapy to
undergraduate medical students is still unsatisfactory.
Because clinical teachers are an important role model for
medical students, it is of interest to know whether this
extends to therapeutic decision-making. The aim of this
study was to find out which factors contribute to the drug
choices made by medical students and their teachers
(general practitioners and clinical specialists).
Methods Final-year medical students (n=32), and general
practitioners (n=29), lung specialists (n=26), orthopaedic
surgeons (n=24), and internists (n=24) serving as medical
teachers from all eight medical schools in the Netherlands
participated in the study. They were asked to prescribe
treatment (drug or otherwise) for uncomplicated (A) and
complicated (B) written patient cases and to indicate which
factors influenced their choice of treatment, using a list of
factors reported in the literature to influence drug prescribing.
Results Final-year medical students primarily based their drug
choice onthe factors ‘effectivenessof the drugs’and ‘examples
from medical teachers’. In contrast, clinical teachers primarily
based their drug choice on the factors ‘clinical experience’,
‘effectiveness of the drugs’, ‘side effects of the drugs’,
‘standard treatment guidelines’,a n d‘scientific literature’.
Conclusions Medical teachers would appear to base their
drug choice mainly on clinical experience and drug-related
factors, whereas final-year medical students base their drug
choice mainly on examples provided by their medical
teachers. It is essential that medical teachers clearly explain
to their students how they arrive at a specific choice of
medication since medical students tend to copy the
therapeutic drug choices from their teachers, mainly
because of a lack of experience. Presenting students with
clinical therapeutic problems early during undergraduate
training will not only give them a chance to gain experience
in solving medical problems but will also give meaning to
what they are studying as opposed to merely reproducing
what they learn or copying what they are told.
Keywords Therapeuticreasoning.Drugtreatmentchoice.
Undergraduateteaching.Medicalstudents.
Pharmacotherapy
Introduction
Unlike diagnostic reasoning [1, 2], little is known about
therapeutic reasoning, the process by which doctors make a
choice of treatment [3]. This part of the consultation is
often regarded simply as a matter of knowing which drug to
prescribe for a certain condition rather than as a reasoned
choice [4]. Experienced doctors rely on their knowledge
when prescribing drugs for common ailments [4, 5], often
having two to five potential drug and non-drug treatments
for the disease or symptom(s) in their mental ‘standard
treatment guideline’. They make their choice of these
options heuristically [6]. This means that doctors may not
be conscious of the assumed value judgement and logic
underlying their therapeutic decision. In turn, this lack of
awareness may make it difficult for medical teachers to
explain to medical students how they arrive at a certain
therapeutic choice. In addition, teaching in clinical disciplines
tends to be focussed on symptoms and making an appropriate
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of drug treatment or pharmacotherapy [3]. This may explain
in part why many graduates feel under-prepared to take on
prescribing responsibilities after graduation [7].
In order to gain insight into the therapeutic decision-
making process, we investigated whether there are differences
in the factors contributing to the drug choices of final-year
medical students and their teachers (general practitioners and
clinical specialists).
Materials and methods
Final-year medical students and medical teachers in four
clinical specialities (general practice, pulmonology, orthopae-
dics, and internal medicine) from all eight medical schools in
the Netherlands participated in this study. The heads of the
above-mentioned departments were asked to select five
specialists to participate and in addition the heads of the
departments ofgeneral practicewereasked toselectrandomly
eight final-year medical students (because general practice
medicine is the last clerkship before graduation).
Three clinical patient cases (bronchial asthma, osteoar-
thritis and essential hypertension) with two levels of
complexity (A and B) were developed in consultation with
clinical specialists and clinical pharmacologists from the VU
University Medical Center in Amsterdam, the Netherlands
(Table1). Cases identified as Awere uncomplicated, whereas
B was a more complicated version of A involving
comorbidity and comedication. The participants recorded
their choice of drug and/or non-drug treatment on a form.
The pulmonology, orthopaedics and internal medicine
specialists completed the patient cases for their own specialty
only, whereas the general practitioners and the final-year
medical students completed all three patient cases.
After the participants had made their treatment choice,
they were given a list of drug choice-related factors (see
below) that are mentioned in the literature as contributing to
therapeutic decision-making [5, 6, 8–11]. The participants
were asked to indicate to what extent each of the 14 factors
had contributed to the choice of treatment for each patient
case (0 = to no extent at all, 1 = to some extent, 2 = to a
considerable extent, 3 = to a decisive extent).
Data collection and statistical analysis
The generic names of drugs were used, and prescribed
drugs were classified into groups according to the Dutch
Pharmacotherapy Compendium [12]. The primary outcome
scores on drug choice-related factors were described by
means including 95% confidence intervals. A one-way
ANOVA in combination with a least-squared difference test
was performed to investigate the differences in each drug
choice-relatedfactoramong the students, general practitioners
Table 1 Summary of the written patient cases presented to the participants for choosing a (drug) treatment
Patient case Uncomplicated (A) vs
complicated (B)
Situated in general practice or the outpatient clinic
Bronchial asthma A Woman, age 22. History: -
Currently: Acute asthma attack a few hours ago, lasting about 5min.
Works in pet shop. Working diagnosis: bronchial asthma
B Woman, age 22. History: migraine for 6months. Takes acetaminophen
2×500mg and metoclopramide supp. 20mg during migraine attack.
No attacks since using propranolol tab. 80mg daily
Currently: Acute asthma attack a few hours ago, lasting about 5min.
Works in pet shop. Working diagnosis: bronchial asthma
Osteoarthritis A Woman, age 63. History: -
Currently: increasing pain in right knee for a few weeks. Working diagnosis: osteoarthritis
B Woman, age 61. History: osteoarthritis in right knee for 10years.
Ibuprofen tab. 400mg when necessary for 1year; no pain
Currently: stomach pain for 7days. Working diagnosis: NSAID-related gastric symptoms
Essential hypertension A Woman, age 52. History: -
Currently: high blood pressure detected during a sports physical examination.
No complaints. Now: BP 160/105 mmHg. Working diagnosis: essential hypertension
B Man, age 62. History: myocardial infarction in 1999. Since then: atenolol
50mg daily, acetosal 80mg daily. Six weeks ago: recurrent high blood pressure
170/105mmHg; diet and exercise advice
Currently: control visit: BP 170/100mmHg. Working diagnosis: essential hypertension,
after 6weeks of not responding to diet, exercise advice and atenolol
408 Eur J Clin Pharmacol (2010) 66:407–412and clinical specialists. We also compared the students versus
medical teachers (i.e. general practitioners and specialists).
The model assumptions were investigated by residual
analysis. A P-value <0.05 was considered statistically
significant. Statistical analyses were performed using SPSS
15.0 (SPSS, Chicago, IL).
Results
Thirty-two final-year medical students, 29 general practi-
tioners and 74 clinical specialists (26 lung specialists, 24
orthopaedic surgeons and 24 internists) participated in the
study. They prescribed 128, 116 and 148 drug and non-drug
treatments respectively (see Table 2). In general, the drugs
prescribed by medical students and general practitioners
were similar, whereas clinical specialists prescribed relatively
more potent drugs out of a broader range of drug classes.
The contribution of the various factors to the drug choice
of the students, general practitioners and clinical specialists
is shown in Table 3. Since there was no difference in the
factors influencing the choice of treatment for A and B
cases, the scores of the two versions were pooled. Students
based their drug choice to a considerable extent (mean
score ≥2 on a scale of 0–3) on the factors ‘effectiveness of
the drugs’ and ‘examples from clinical teachers’.I n
Table 2 The treatments prescribed (%) by students, general practitioners and specialists for the uncomplicated (A) and complicated (B) cases
Final-year medical
students (n=32)
Percentage General practitioners
(n=29)
Percentage Clinical specialists
(n=26, 24, 24)
Percentage
Bronchial
asthma
A1β2 agonist 90 β2 agonist 94 β2 agonist 52
2 β2 agonist + steroid 5 β2 agonist + steroid 6 β2 agonist + steroid 44
3 Other 5 Other 4
B1β2 agonist 40 β2 agonist 41 β2 agonist + steroid 40
2 Steroid 25 β2 agonist + steroid 24 β2 agonist 20
3 Β2 agonist + steroid 20 β2 agonist + steroid + stop
beta antagonist
24 β2 agonist + stop beta
antagonist
8
4 Other 15 Other 11 β2 agonist + steroid + stop
beta antagonist
8
β2 agonist + steroid +
prednisone
8
Other 16
Osteoarthritis A 1 Prostaglandin
inhibitor
60 Non-opioid analgesics 53 Prostaglandin inhibitor 70
2 Non-opioid
analgesics
25 Prostaglandin inhibitor 30 Prostaglandin inhibitor + PPI 13
3 Prostaglandin
inhibitor + PPI
15 Prostaglandin inhibitor + PPI 17 Non-opioid analgesics 13
Other 4
B 1 PPI 40 Non-opioid analgesics 61 PPI 35
2 Prostaglandin
inhibitor + PPI
35 Prostaglandin inhibitor + PPI 17 Non-opioid analgesics 22
3 Prostaglandin
inhibitor
10 Prostaglandin inhibitor 11 Prostaglandin inhibitor + PPI 17
4 Opioid 5 PPI 11 Prostaglandin inhibitor 13
5 Other 10 Other 13
Essential
hypertension
A 1 Diuretics 50 Diuretics 42 Beta antagonist 36
2 Beta antagonist 41 Lifestyle advice 27 Diuretics 28
3 Lifestyle advice 9 Beta antagonist 26 Lifestyle advice 24
ACE inhibitor 5 ACE inhibitor 8
Calcium antagonist 4
B 1 Diuretics 46 Beta antagonist 48 Beta antagonist 44
2 ACE inhibitor 23 Diuretics 26 ACE inhibitor 24
3 Beta antagonist 18 ACE inhibitor 21 Diuretics 12
4 Lifestyle advice 9 Lifestyle advice 5 Beta antagonist + diuretics 12
5 Other 4 Other 8
PPI Proton pump inhibitor
Eur J Clin Pharmacol (2010) 66:407–412 409contrast, both general practitioners and clinical specialists
based their drug choice to a considerable extent on the
factors ‘clinical experience’, ‘effectiveness of the drug(s)’,
and ‘side effects of the drug(s)’. In addition, general
practitioners based their drug choice to a considerable
extent on ‘standard treatment guidelines’ and clinical
specialists on ‘scientific literature’.
Students attached significantly more importance to ‘exam-
ples from clinical teachers’ when making their treatment
choice than did the general practitioners and clinical special-
ists, whereas general practitioners and clinical specialists
placed more emphasis on three practice-related factors (‘own
clinical experience’, ‘patients’ convenience’ and ‘compliance
of the patient’) and two drug-related factors [‘side effects of
the drug(s)’ and ‘therapeutic spectrum of the drug(s)’].
Besides this, the general practitioners attached significantly
more importance to the drug choice-related factors ‘costs of
the drug(s)’ and ‘education and postgraduate education’
compared to the students, whereas the clinical specialists
rated the drug-related factors ‘effectiveness of the drug(s)’,
‘scientific literature’,a n d‘information from the pharmaceu-
tical industry’ significantly higher than the students.
Discussion
We found that medical teachers base their drug choice
mainly on the factors ‘clinical experience’, ‘effectiveness of
the drug(s)’, ‘side effects of the drug(s)’, ‘standard
treatment guidelines’ and ‘scientific literature’, whereas
final-year medical students base their drug choice mainly
on the factors ‘effectiveness of the drug(s)’ and ‘examples
from clinical teachers’. That medical teachers base their
choice mainly on ‘clinical experience’ is consistent with
theories from cognitive psychology about how clinical
(diagnostic) expertise is achieved [2, 3, 13]. During
everyday practice, doctors build up so-called cognitive
networks of organised (therapeutic) knowledge and exper-
tise [3], generating readily accessible treatment scripts.
When a doctor is presented with a patient with one or more
ailments, a specific treatment script is selected, depending
on the level of complexity of the problem and the doctor’s
prior experience. This selection is done subconsciously
when the medical problem is simple but occurs in a
conscious and analytical way when the medical problem
is complex.
Table 3 Importance of factors affecting drug choice, as rated by students, general practitioners and clinical specialists
Final-year
medical students
(n=32)
General
practitioners
(n=29)
Clinical
specialists
(n=26, 24, 24)
ANOVA
overall p-value
Practice-related factors
Own clinical experience 1.59 (1.40–1.79) 2.32 (2.19–2.45)
b 2.06 (1.94–2.17)
b <0.001
Easy administration
of the drug(s)
1.00 (0.83–1.17) 1.08 (0.88–1.29) 0.92 (0.77–1.07) 0.34
Patients’ convenience 1.57 (1.39–1.76) 1.90 (1.73–2.06)
b 1.83 (1.70–1.96)
b 0.013
Compliance of the patient 1.44 (1.28–1.60) 1.79 (1.62–1.96)
b 1.78 (1.64–1.91)
b 0.002
Drug-related factors
Effectiveness of the drug(s) 2.19 (2.07–2.31) 2.28 (2.14–2.41) 2.50 (2.40–2.60)
b <0.001
Side effects of the drug(s) 1.55 (1.38–1.73) 2.19 (2.01–2.37)
b 2.00 (1.86–2.13)
b <0.001
Costs of the drug(s) 0.88 (0.72–1.04) 1.40 (1.21–1.59)
b 0.96 (0.83–1.09) <0.001
Therapeutic spectrum
of the drug(s)
1.05 (0.89–1.21) 1.64 (1.44–1.84)
b 1.67 (1.52–1.82)
b <0.001
Information-related factors
Standard treatment
guidelines (STG)
1.98 (1.82–2.14) 2.17 (1.99–2.35) 1.73 (1.58–1.87)
b <0.001
Scientific literature 1.23 (1.05–1.48) 1.51 (1.31–1.71) 2.10 (1.98–2.23)
b <0.001
The opinion of colleagues 1.18 (1.02–1.34) 0.78 (0.60–0.95)
b 1.10 (0.97–1.24) 0.001
Information from the
pharmaceutical industry
0.60 (0.45–0.74) 0.34 (0.23–0.46)
b 0.81 (0.69–0.93)
b <0.001
Teaching-related factors
Examples from clinical teachers 2.06 (1.93–2.20)
a 0.60 (0.45–0.76) 1.08 (0.93–1.23) <0.001
Education and
postgraduate education
1.30 (1.11–1.48) 1.68 (1.50–1.86)
b 1.30 (1.15–1.44) 0.003
Pooled data are presented as mean (95% CI). Differences among groups were analysed by means of the least-squared difference test:
aP<0.05
students vs. general practitioners and clinical specialists,
bP<0.05 vs. students
Factors with a score of score ≥2 on a scale of 0–3 were considered to have contributed to a considerable extent to the drug choice
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their choice of treatment on the ‘effectiveness of the drug
(s)’, students’ knowledge of drug effectiveness is mainly
theoretical, since they have little or no prescribing
experience, whereas medical teachers’ knowledge of drug
effectiveness is both theoretical and practical, based on the
response of other patients to the medication in question.
The same also holds for drug side effects: students have
theoretical knowledge whereas medical teachers have both
theoretical and practical knowledge. This practical knowledge
gained through experience is probably why medical teachers
rated this factor significantly higher than medical students.
Clinical specialists, in contrast to the general practitioners,
rated the drug choice-related factor ‘scientific literature’
significantly higher than medical students. This might reflect
a difference in patient populations seen by the two groups of
medical teachers. Clinical specialists are accustomed to
treating more complicated and severely ill patients who are,
for the most part, referred by the general practitioner. In these
cases, they frequently prescribe more potent and newer drugs
[14]. Clinical specialists learn about these new drugs (mostly
before their launch) from drug company advertising, the
literature or at meetings [15]. Thiscould account also, atleast
partly, for the significantly higher value assigned by clinical
specialists to the drug choice-related factor ‘information from
thepharmaceuticalindustry’.Generalpractitioners,incontrast
toclinicalspecialists,basedtheirdrugchoicetoaconsiderable
extent on the drug choice-related factor ‘standard treatment
guidelines’.Theseguidelines,whichhavebeenformulatedfor
manycommonailmentsanddiseases,provide evidence-based
recommendations for the treatment of ‘standard’ patients. In
the Netherlands, general practitioners have a so-called
gatekeeper function with regard to specialist care, and the
use of national guidelines ensures a more uniform referral
practice.Conversely,clinicalspecialistsmightpossiblyadhere
more to international guidelines.
That students nearing graduation based their treatment
choices on the example of their medical teachers is
consistent with the copying behaviour of medical
students [16, 17]. Medical students have little opportunity
to gain therapeutic experience, and so their reliance on the
example of their teachers is not surprising. This means
that clinical teachers need to explain the arguments
underlying their treatment choice explicitly to their
students [18, 19].
Before interpreting the results, the strengths and limi-
tations of this study need to be addressed. As far as we
know, this is the first nationwide study to investigate
whether there are differences between medical students and
their teachers in how they choose a medication. While we
included 103 clinical teachers, we had only 32 final-year
students. This was unfortunately inevitable because data
collection occurred at one moment during the students’
final clerkship, general practice. However, the students
were recruited from all eight medical schools in the
Netherlands, and since there were no significant differences
in baseline characteristics (i.e. gender, age, etc.) or mean
examination score during training, it is very likely that the
included population was representative. Lastly, it may not
be possible to generalise these results to medical students
and teachers in other countries because of differences
between medical curricula in various countries. However,
our findings may be generalisable to medical students in
countries that have a sequentially designed medical curric-
ulum as in the Netherlands.
In conclusion, we found that final-year medical students
base their prescribing choices on the examples of their
teachers. To improve rational prescribing, medical curricula
should pay more attention not only to diagnostic reasoning
but also to therapeutic reasoning. Incorporation of specific
clinical pharmacology and therapeutics courses into the
medical curriculum [20] may help students bridge the gap
between (pre-clinical) theoretical learning and (clinical)
practical learning, and between undergraduate and post-
graduate training. Presenting students with clinical thera-
peutic problems early during undergraduate training will
not only give them a chance to gain experience in solving
medical problems but will also give meaning to what they
are studying as opposed to merely reproducing what they
learn or copying what they are told [21, 22]. Replication of
our findings in further studies might provide more insight
into the process of therapeutic reasoning and contribute to
optimisation of the therapeutic training of our future
doctors.
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